Khalid Ishaque

Khalid Ishaque is an experienced executive in the medical technology sector, currently serving as an Independent Board Member at BioSerenity, focusing on connected medical solutions for chronic disease management. Previously, Khalid held the position of Strategy Advisor at Bioinduction, contributing to advancements in neuro-surgical interventions. As CEO and Board Member of Pixium-Vision, leadership was provided in developing bionic vision restoration systems to aid severely visually impaired patients. Khalid's extensive tenure at Boston Scientific encompassed multiple roles, including General Manager for Neuromodulation International, overseeing international sales and marketing, and driving the global market entry for key neuromodulation technologies. Khalid's educational background includes advanced training from prestigious institutions such as Stanford and Harvard Business School, with degrees in engineering and management fields from esteemed universities.